Dattatraya Patil

Zitiert von

	Alle	Seit 2019
Zitate	1958	1713
h-index	23	22
i10-index	50	46

400

200

100

300

20162017201820192020202120222023202431 56 134 206 290 333 356 381 141

Öffentlicher Zugriff

Alle anzeigen

39 Artikel

6 Artikel

verfügbar

nicht verfügbar

Basierend auf Fördermandaten

Koautoren

Viraj MasterProfessor and Fray F. Marshall Chair of Urological Research, Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Martin G SandaProfessor and Chairman of Urology, Emory University School of MedicineBestätigte E-Mail-Adresse bei emory.edu
Christopher FilsonAssociate Professor, Department of Urology, Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Ithaar H. Derweesh, MDProfessor of Urology and Radiology; Program Director, Urologic Oncology Fellowship, UC San DiegoBestätigte E-Mail-Adresse bei health.ucsd.edu
Mehmet Asim BilenWinship Cancer Institute of Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Yasuhisa FujiiTokyo Med Dent UnivBestätigte E-Mail-Adresse bei tmd.ac.jp
Margaret MeagherUniversity of California, San DiegoBestätigte E-Mail-Adresse bei ucsd.edu
Reza Nabavizadeh, MDMayo ClinicBestätigte E-Mail-Adresse bei mayo.edu
Brittney H. Cotta, MDAttending Surgeon, MD Anderson Cancer CenterBestätigte E-Mail-Adresse bei ucsd.edu
Lori SokollJohns Hopkins UniversityBestätigte E-Mail-Adresse bei jhmi.edu
David HowardDepartment of Health Policy and Management, Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Mark A RubinProfessor & Director Department for BioMedical Research, University of BernBestätigte E-Mail-Adresse bei dbmr.unibe.ch
Omer KucukEmory UniversityBestätigte E-Mail-Adresse bei emory.edu
Haydn KissickEmory UniversityBestätigte E-Mail-Adresse bei emory.edu
David SchusterProfessor of Radiology and Imaging Sciences, Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Meredith M. Regan, ScDDana-Farber Cancer Institute, Harvard Medical SchoolBestätigte E-Mail-Adresse bei ds.dfci.harvard.edu
Carlos S. Moreno, PhDAssociate Professor, Pathology, Biomedical Informatics, Emory UniversityBestätigte E-Mail-Adresse bei emory.edu
Wen LiuNew York University Department of UrologyBestätigte E-Mail-Adresse bei nyulangone.org
HEQIONG WangBiostatistician, Emory University, University of floridaBestätigte E-Mail-Adresse bei EMORY.EDU
Shipra AryaProfessor of Surgery, Stanford UniversityBestätigte E-Mail-Adresse bei stanford.edu

Folgen

Dattatraya Patil

Sonstige NamenDatta Patil

Emory University, Atlanta, GA

Bestätigte E-Mail-Adresse bei emory.edu

Urological cancers Biomarkers Biostatistics Health services research


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Multicenter evaluation of the prostate health index to detect aggressive prostate cancer in biopsy naive men C de la Calle, D Patil, JT Wei, DS Scherr, L Sokoll, DW Chan, J Siddiqui, ... The Journal of urology 194 (1), 65-72, 2015	207	2015
Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer MG Sanda, Z Feng, DH Howard, SA Tomlins, LJ Sokoll, DW Chan, ... JAMA oncology 3 (8), 1085-1093, 2017	143	2017
Semantics in active surveillance for men with localized prostate cancer—results of a modified Delphi consensus procedure SM Bruinsma, MJ Roobol, PR Carroll, L Klotz, T Pickles, CM Moore, ... Nature Reviews Urology 14 (5), 312, 2017	103	2017
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ... European urology 75 (3), 523-531, 2019	72	2019
The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ... BJU international 121 (5), 737-744, 2018	64	2018
Patient frailty and discharge disposition following radical cystectomy JA Pearl, D Patil, CP Filson, S Arya, M Alemozaffar, VA Master, K Ogan Clinical genitourinary cancer 15 (4), e615-e621, 2017	61	2017
Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus JE Abel, PE Spiess, V Margulis, VA Master, M Mann, K Zargar-Shoshtari, ... Journal of Urology 198 (2), 281-288, 2017	57	2017
Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer AC McDonald, M Vira, J Shen, M Sanda, JD Raman, J Liao, D Patil, ... The Prostate 78 (6), 411-418, 2018	50	2018
Adoption of Prebiopsy Magnetic Resonance Imaging for Men Undergoing Prostate Biopsy in the United States W Liu, D Patil, DH Howard, RH Moore, H Wang, MG Sanda, CP Filson Urology 117, 57-63, 2018	49	2018
epiCaPture: a urine DNA methylation test for early detection of aggressive prostate cancer E O’Reilly, AV Tuzova, AL Walsh, NM Russell, O O’Brien, S Kelly, ... JCO precision oncology 3, 1-18, 2019	43	2019
Onodera's Prognostic Nutritional Index as an independent prognostic factor in clear cell renal cell carcinoma MS Broggi, D Patil, Y Baum, PT Nieh, M Alemozaffar, JG Pattaras, K Ogan, ... Urology 96, 99-105, 2016	41	2016
MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement AI Khan, DA Reiter, A Sekhar, P Sharma, NM Safdar, DH Patil, SP Psutka, ... Applied Physiology, Nutrition, and Metabolism 44 (8), 814-819, 2019	39	2019
A four‐group urine risk classifier for predicting outcomes in patients with prostate cancer SP Connell, M Yazbek‐Hanna, F McCarthy, R Hurst, M Webb, H Curley, ... BJU international 124 (4), 609-620, 2019	38	2019
Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma KS Kim, RR Sekar, D Patil, MA Dimarco, HT Kissick, MA Bilen, ... OncoImmunology 7 (4), e1413519, 2018	36	2018
Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, ... European Journal of Radiology 102, 1-8, 2018	35	2018
Circulating microRNAs in plasma among men with low‐grade and high‐grade prostate cancer at prostate biopsy AC McDonald, M Vira, V Walter, J Shen, JD Raman, MG Sanda, D Patil, ... The Prostate 79 (9), 961-968, 2019	34	2019
Safety and efficacy of ureteral stent placement at the bedside using local anesthesia P Nourparvar, A Leung, AB Shrewsberry, AD Weiss, D Patil, H Atallah, ... The Journal of urology 195 (6), 1886-1890, 2016	34	2016
Detection of prostate cancer‐specific transcripts in extracellular vesicles isolated from post‐DRE urine KL Pellegrini, D Patil, KJS Douglas, G Lee, K Wehrmeyer, M Torlak, ... The Prostate 77 (9), 990-999, 2017	33	2017
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, ... Cancer 127 (12), 1974-1983, 2021	32	2021
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing … YS Baum, D Patil, JH Huang, S Spetka, M Torlak, PT Nieh, M Alemozaffar, ... Asian Journal of Urology 3 (1), 20-25, 2016	31	2016

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren